Chlorpheniramine maleate and Peripheral sensory neuropathy - a phase IV clinical study of FDA data

Summary:

Peripheral sensory neuropathy is reported as a side effect among people who take Chlorpheniramine maleate (chlorpheniramine maleate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cytarabine, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Peripheral sensory neuropathy when taking Chlorpheniramine maleate. It is created by eHealthMe based on reports of 7,278 people who have side effects when taking Chlorpheniramine maleate from the FDA, and is updated regularly.

What is Chlorpheniramine maleate?

Chlorpheniramine maleate has active ingredients of chlorpheniramine maleate. It is often used in allergies. eHealthMe is studying from 7,632 Chlorpheniramine maleate users. Check the latest studies of Chlorpheniramine maleate.

What is Peripheral sensory neuropathy?

Peripheral sensory neuropathy (damage to one or more of your peripheral nerves) is found to be associated with 571 drugs and 714 conditions by eHealthMe. Check the latest studies of Peripheral sensory neuropathy.

On Jul, 11, 2026

7,278 people reported to have side effects when taking Chlorpheniramine maleate.
Among them, 12 people (0.16%) have Peripheral sensory neuropathy.

Could Chlorpheniramine maleate cause Peripheral sensory neuropathy?

Among these 12 people:

How long have people been on Chlorpheniramine maleate when they have Peripheral sensory neuropathy? *

What is the gender of people who have Peripheral sensory neuropathy when taking Chlorpheniramine maleate? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Peripheral sensory neuropathy when taking Chlorpheniramine maleate? *

What are other drugs people take besides Chlorpheniramine maleate? *

What are other side effects people have besides Peripheral sensory neuropathy? *

Ileus Paralytic (obstruction of the intestine due to paralysis of the intestinal muscles): 9 people, 75.00%
Rhinorrhea (watery mucus discharge from the nose): 9 people, 75.00%
Blood Alkaline Phosphatase Increased: 9 people, 75.00%
Blood Creatinine Increased: 9 people, 75.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 9 people, 75.00%
White Blood Cell Count Decreased: 9 people, 75.00%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 9 people, 75.00%
Pleural Effusion (water on the lungs): 9 people, 75.00%
Anaemia (lack of blood): 9 people, 75.00%
Tumor Lysis Syndrome: 9 people, 75.00%

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 9 people, 75.00%
Rashes (redness): 1 person, 8.33%
Nausea (feeling of having an urge to vomit): 1 person, 8.33%
Lung Cancer Metastatic (lung cancer spreads to other parts): 1 person, 8.33%
Intestinal Obstruction: 1 person, 8.33%
Colon Cancer: 1 person, 8.33%
Back Pain: 1 person, 8.33%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Chlorpheniramine maleate and have Peripheral sensory neuropathy?

- Check whether Peripheral sensory neuropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Chlorpheniramine maleate:

Chlorpheniramine maleate (7,632 reports)

Browse all side effects of Chlorpheniramine maleate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peripheral sensory neuropathy:

Peripheral sensory neuropathy (571 drugs)

Browse all the conditions that are associated with Peripheral sensory neuropathy:

Peripheral sensory neuropathy (714 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on chlorpheniramine maleate (the active ingredients of Chlorpheniramine maleate) and Chlorpheniramine maleate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.